Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2024

Variations in New Clinical Trial Designs for Emerging CEP Devices

Presenter: Alexandra Lansky

October 30, 2024

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation TCT 2023

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

Presenter: Edip Gurol

October 26, 2023

Presentation TCT 2023

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

Presenter: Jens Erik Nielsen-Kudsk

October 25, 2023

Presentation TCT 2023

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Presenter: Saibal Kar

October 25, 2023

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Presenter: Julia Seeger

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

Presentation Miami Valves 2023

CPVT: The Only Thing that Scares me in the Inherited Arrhythmia Clinic

Presenter: Andrew Krahn

February 03, 2023

Presentation ESC 2022

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

Presenter: Axel Bauer

August 28, 2022

Presentation TCT 2021

DAPT Duration in the Afib Patient: Where Do We Stand?

Presenter: Renato Lopes

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Presenter: Davide Cao

November 05, 2021

Presentation CACI 2019

Caso clínico: Estrategias no farmacológicas de prevención cardioembólica en la fibrilación auricular

Presenter: Ricardo Costantini

November 29, 2019

Presentation CACI 2019

Caso clínico: Estrategias no farmacológicas de prevención cardioembólica en la fibrilación auricular

Presenter: Ricardo Costantini

November 29, 2019

Presentation TCT 2019

When the Primary Endpoint Is Missed: The CABANA Case Study

Presenter: Bernard Gersh

September 27, 2019

Presentation TCT Abstracts Posters 2018

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Presenter: Hyungdon Kook

September 25, 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticouagulants

Presentation ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Presentation AHA 2017

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Presenter: Akihiko Nogami

November 13, 2017

Presentation TVT 2017

Delayed Cardiac Arrest After On-Pump Transcatheter Valve Trans-septal Mitral Valve-in-Valve Replacement Combined With Alcohol Septal Ablation to Relieve Left Ventricular Outflow Tract Obstruction: A Cautionary Tale

Presenter: Horst Sievert, Robert L. Smith, Hasan Ahmad, MD

June 16, 2017

Advertisement

Variations in New Clinical Trial Designs for Emerging CEP Devices

DoReMe: Are Inotropes Helpful or Harmful?

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

CPVT: The Only Thing that Scares me in the Inherited Arrhythmia Clinic

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

DAPT Duration in the Afib Patient: Where Do We Stand?

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Caso clínico: Estrategias no farmacológicas de prevención cardioembólica en la fibrilación auricular

Caso clínico: Estrategias no farmacológicas de prevención cardioembólica en la fibrilación auricular

When the Primary Endpoint Is Missed: The CABANA Case Study

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Delayed Cardiac Arrest After On-Pump Transcatheter Valve Trans-septal Mitral Valve-in-Valve Replacement Combined With Alcohol Septal Ablation to Relieve Left Ventricular Outflow Tract Obstruction: A Cautionary Tale

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content